Dianthus Therapeutics, Inc.

DNTH

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001690585

SEC filings (opens in a new tab)

In the last 90 days, Dianthus Therapeutics, Inc. insiders filed 0 open-market purchases and 8 sales; 269 institutions reported holding it in 13F filings for Q2 2026, worth $6.40B in total; no superinvestor holds it.

Q4 2025 vs. Q3 2025

How the institutions holding Dianthus Therapeutics, Inc. changed between Q3 2025 and Q4 2025.

All holders in Q4 2025 All holders in Q3 2025

13F holders of DNTH: Q3 2025 compared with Q4 2025
Measure	Q3 2025	Of which not filed for Q4 2025	Q4 2025	Change
Holders	140	3	166	+29
Shares	46.8M	11.3K	49.1M	+2.30M (+4.9%)
Value	$1.84B	$445.4K	$2.02B	+$182.0M (+9.9%)

3 institutions that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so the changes leave them out.

New holders (47)

Institutions that held Dianthus Therapeutics, Inc. at the end of Q4 2025 but not at the end of Q3 2025.

Institutions new to DNTH in Q4 2025
Institution	Shares	Value	% of portfolio
Spruce Street Capital LP	297,437	$12.3M	4.05%
ExodusPoint Capital Management, LP	246,788	$10.2M	0.11%
Iron Triangle Partners LP	230,730	$9.51M	1.09%
Squarepoint Ops LLC	207,119	$8.54M	0.02%
Atika Capital Management LLC	134,528	$5.54M	0.77%
Algert Global LLC	130,326	$5.37M	0.08%
SummitTX Capital, L.P.	87,926	$3.62M	0.11%
Neuberger Berman Group LLC	87,782	$3.62M	0.00%
Public Sector Pension Investment Board	48,477	$2.00M	0.01%
Two Sigma Investments, LP	48,400	$1.99M	0.00%
Cinctive Capital Management LP	45,906	$1.89M	0.11%
Jane Street Group, LLC	45,833	$1.89M	0.00%
Renaissance Technologies LLC	32,100	$1.32M	0.00%
Swiss National Bank	31,400	$1.29M	0.00%
Superstring Capital Management LP	26,249	$1.08M	0.58%
Ishara Investments LP	24,000	$989.0K	1.15%
Two Sigma Advisers, LP	22,000	$906.6K	0.00%
Profund Advisors LLC	21,340	$879.4K	0.03%
Lighthouse Investment Partners, LLC	20,000	$824.2K	0.03%
SG Americas Securities, LLC	18,565	$765.0K	0.00%
Aquatic Capital Management LLC	16,829	$693.5K	0.02%
BIT Capital GmbH	15,000	$618.1K	0.03%
Victory Capital Management Inc	14,790	$609.5K	0.00%
Seven Fleet Capital Management LP	14,651	$603.8K	0.41%
Fisher Asset Management, LLC	13,948	$574.8K	0.00%
XTX Topco Ltd	13,342	$549.8K	0.01%
PSP Research LLC	12,725	$524.4K	0.46%
UBS Asset Management Americas Inc	12,073	$497.5K	0.00%
Shay Capital LLC	11,000	$453.3K	0.07%
Fox Run Management, L.L.C.	10,510	$433.1K	0.07%
Qube Research & Technologies Ltd	10,294	$424.2K	0.00%
Persistent Asset Partners Ltd	9,739	$401.3K	0.19%
Gsa Capital Partners LLP	9,715	$400.0K	0.03%
Janus Henderson Group PLC	8,400	$346.0K	0.00%
Dark Forest Capital Management LP	7,008	$288.8K	0.01%
Glenmede Trust Co NA	6,345	$261.5K	0.00%
Intech Investment Management LLC	6,001	$247.3K	0.00%
Trexquant Investment LP	5,216	$215.0K	0.00%
KLP Kapitalforvaltning AS	3,400	$140.1K	0.00%
Zurcher Kantonalbank (Zurich Cantonalbank)	3,276	$135.0K	0.00%
Quarry LP	2,400	$98.9K	0.02%
Caitong International Asset Management Co., Ltd	1,047	$43.1K	0.01%
Group One Trading, L.P.	832	$34.3K	0.00%
EFG International AG	500	$20.6K	0.00%
Antipodes Partners Ltd	459	$18.9K	0.00%
BNP PARIBAS ASSET MANAGEMENT Holding S.A.	216	$9.00K	0.00%
SageView Advisory Group, LLC	7	$289	0.00%

Sold out (18)

Institutions that held Dianthus Therapeutics, Inc. at the end of Q3 2025 and filed for Q4 2025 without it.

Institutions that sold out of DNTH in Q4 2025
Institution	Shares, Q3 2025	Value, Q3 2025
Vestal Point Capital, LP	1,180,000	$46.4M
Balyasny Asset Management LLC	443,703	$17.5M
5AM Venture Management, LLC	365,053	$14.4M
Ikarian Capital, LLC	346,001	$13.6M
Alphabet Inc.	208,697	$8.21M
Boothbay Fund Management, LLC	138,963	$5.47M
Caption Management, LLC	138,561	$5.45M
Adage Capital Partners GP, L.L.C.	77,000	$3.03M
Longaeva Partners L.P.	25,000	$983.8K
Y-Intercept (Hong Kong) Ltd	18,568	$730.7K
Quadrature Capital Ltd	13,939	$548.5K
Omers Administration Corp	12,100	$476.1K
Raymond James Financial Inc	11,245	$442.5K
Ethic Inc.	5,530	$217.6K
Tower Research Capital LLC (TRC)	1,443	$56.8K
Crowley Wealth Management, Inc.	221	$8.70K
Principal Securities, Inc.	11	$433
Montag A & Associates Inc	9	$355

Not filed for Q4 2025 yet (3)

Institutions that held Dianthus Therapeutics, Inc. at the end of Q3 2025 and haven't filed a 13F for Q4 2025. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding DNTH in Q3 2025 that haven't filed for Q4 2025
Institution	Shares, Q3 2025	Value, Q3 2025
Glenmede Investment Management, LP	5,415	$213.1K
Point72 Asia (Singapore) Pte. Ltd.	3,004	$118.2K
Point72 (DIFC) Ltd	2,901	$114.1K